News dal mondo
21
Gen
Eight current drivers of the API production revolution
API manufacturing has always been about innovating to cater for shifting demand patterns, but the recent coronavirus pandemic has raised further questions. Here we list eight major trends and considerations as API production enters a new age..[CPhI]
25
Feb
Indian drugmakers look to reduce dependence on China-made APIs
Since June 2020, India and China have seen their relations sour due to skirmishes at the border. And...
24
New Zealand seeks feedback on adopting new PIC/S Guide to GMPs
The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) is holding a public consultation...
FDA Revises Nitrosamine Guidance to Extend Recommended Timeframe for Nitrosamine Risk Assessments to March 31, 2021
To ensure the safety of the U.S. drug supply, the guidance recommends that manufacturers should conclude...
23
European Pharmacopoeia: Rapid implementation of the revised sartan monographs on 1 April 2021
The five monographs on sartans with a tetrazole ring, namely Valsartan (2423), Losartan potassium...
le ultime news
25 Feb
24 Feb
23 Feb
22 Feb
EMA nitrosamine impurities in medicines Update
Covid-19, CdM approva Decreto Legge: prorogato al 27 marzo il divieto di spostamento tra Regioni e Province Autonome
Covid-19: firmata nuova Ordinanza per contenere la diffusione del virus
18 Feb
cGMP Non-Compliance Recap 2020
1 2>>>
